Fujifilm Holdings Corp. is considering buying Hitachi Limited’s diagnostic imaging business, as the Japanese photocopier and camera manufacturer aims to build up its medical business.
Fujifilm has been expanding into healthcare, having recently bought a drug-making business from US-based Biogen Inc. and two biotechnology units from compatriot JXTG Holdings Inc., as growth at its legacy photocopy business stagnates.
The value of the deal would be around 170 billion yen (USD 1.56 billion). Hitachi has been reorganizing its business, selling non-core assets while buying foreign businesses to expand digital businesses. Hitachi is considering various options to raise its corporate value, but there is nothing to disclose at this point.